Rubix LS is a contract medical research organization dedicated to conducting patient-centric research for diseases and cancers that haven't been afforded access. We believe that every patient deserves access to innovative treatments and cures. Our team of experienced researchers and clinicians work tirelessly to develop new therapies and bring hope to those who need it most.
At Rubix LS, our approach to research is centered around the patient. We believe that by putting the patient first, we can develop treatments that are more effective, safer, and more accessible. Our team works closely with patients, caregivers, and advocacy groups to ensure that our research is focused on the needs of the people we serve. We also collaborate with leading academic institutions, hospitals, and biotech companies to stay at the forefront of medical innovation.
RUBIX LS IS FOUNDED
Rubix LS was founded, as a product development company, with the mission that makes a difference in the lives of patients. From the beginning, we have been committed to putting patients first and developing treatments that meet their needs.
FIRST CLINICAL TRIAL BEGINS
Rubix LS conducts its first clinical trial, testing a new therapy for a rare form of osteonecrotic cancer with DoD. The trial results are promising, and the therapy is approved for use in patients.